JAK2-STAT3信号通路在肝细胞癌中的研究进展
作者: |
1廖明媚,
1王成志,
1杨满意,
1潘一峰,
1赵劲风
1 中南大学湘雅医院 卫生部纳米生物技术重点实验室,湖南 长沙 410008 |
通讯: |
赵劲风
Email: zhaojinfeng@hotmail.com |
DOI: | 10.3978/.10.3978/j.issn.1005-6947.2017.01.017 |
基金: | 国家自然科学基金资助项目, 81302075;81272193;81402001 |
摘要
近年来发现,JAK2-STAT3信号通路参与肿瘤细胞的生长、增殖、分化、转移、凋亡。在肝细胞癌(HCC)细胞中的JAK蛋白和STAT蛋白过表达,JAK2-STAT3信号通路与HCC发生发展密切相关。笔者就JAK2-STAT3信号通路在HCC的研究进展做一综述。
关键词:
癌,肝细胞
Janus激酶类
STAT转录因子类
综述文献
Research progress of JAK2-STAT3 signing pathway in hepatocellular carcinoma
CorrespondingAuthor:ZHAO Jinfeng Email: zhaojinfeng@hotmail.com
Abstract
In recent years, JAK2-STAT3 signaling pathway has been found to be involved in the growth, proliferation, differentiation, metastasis and apoptosis of tumor cells. JAK and STAT proteins are overexpressed in hepatocellular carcinoma (HCC) cells, and JAK2-STAT3 signaling pathway is closely related to the occurrence and development of HCC. In this article, the authors overview the research progress of JAK2-STAT3 signaling pathway in HCC.
Keywords: